OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(60)
Release Date
2021
(12)
2023
(8)
2025
(7)
2022
(7)
2011
(5)
2024
(4)
2020
(4)
2015
(3)
2019
(2)
2018
(2)
2012
(2)
2010
(2)
2016
(1)
2013
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS.
Not available
S-EPMC7371380
|
biostudies-literature
Cite
Study of the doubly charmed tetraquark [Formula: see text].
Not available
S-EPMC9203551
|
biostudies-literature
Cite
Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort.
Not available
S-EPMC4432819
|
biostudies-literature
Cite
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.
Not available
S-EPMC6934233
|
biostudies-literature
Cite
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Not available
S-EPMC10336619
|
biostudies-literature
Cite
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
Not available
S-EPMC3309185
|
biostudies-literature
Cite
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
Not available
S-EPMC3014369
|
biostudies-literature
Cite
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3458423
|
biostudies-literature
Cite
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425
|
biostudies-literature
Cite
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Not available
S-EPMC2999830
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets